A detailed history of Wr Wealth Planners, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Wr Wealth Planners, LLC holds 3,175 shares of EDIT stock, worth $10,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,175
Previous 1,675 89.55%
Holding current value
$10,064
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$3.39 - $5.96 $5,085 - $8,940
1,500 Added 89.55%
3,175 $10,000
Q2 2024

Jul 31, 2024

SELL
$4.67 - $7.28 $1,868 - $2,912
-400 Reduced 19.28%
1,675 $7,000
Q1 2024

Jul 31, 2024

BUY
$7.03 - $11.07 $14,587 - $22,970
2,075 New
2,075 $15,000
Q2 2023

Aug 01, 2024

BUY
$6.36 - $11.47 $4,452 - $8,029
700 Added 41.79%
2,375 $19.5 Million
Q1 2023

Aug 01, 2024

BUY
$7.03 - $11.53 $4,921 - $8,071
700 Added 41.79%
2,375 $17.2 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $218M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Wr Wealth Planners, LLC Portfolio

Follow Wr Wealth Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wr Wealth Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wr Wealth Planners, LLC with notifications on news.